Hester Biosciences informs about conference call

31 Jan 2019 Evaluate

Hester Biosciences has informed about submission of a transcript of Earnings Conference Call held by the Management of the Company with investors on 29 January 2019 at 2.00 pm to discuss the Unaudited Standalone Financial Results for the quarter and nine months ended on 31 December 2018.

The above information is a part of company’s filings submitted to BSE.

Hester Biosciences Share Price

1504.40 20.05 (1.35%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×